Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
Crossref DOI link: https://doi.org/10.1007/s12072-017-9792-3
Published Online: 2017-03-21
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Sangheun
Kang, Jung Hyun
Kim, Do Young
Ahn, Sang Hoon
Park, Jun Yong
Kim, Beom Kyung
Kim, Seung Up
Han, Kwang-Hyub
License valid from 2017-03-21